The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.

Final Report CTN-0094

CTN-0094 Team

2023-09-29

Table 1

Harmonized demographics data from the three National Drug Treatment Clinical Trials Network (CTN) opioid use disorder treatment trials (CTN-0027, CTN-0030, CTN-0051, , N= 2492)

27
(N=1269)
30
(N=653)
51
(N=570)
Overall
(N=2492)
Sex
Hispanic 206 (16.2%) 31 (4.7%) 99 (17.4%) 336 (13.5%)
Not Hispanic 1063 (83.8%) 622 (95.3%) 471 (82.6%) 2156 (86.5%)
Age
Mean (SD) 36.9 (11.1) 32.7 (10.2) 33.9 (9.63) 35.1 (10.7)
Median [Min, Max] 35.0 [18.0, 67.0] 30.0 [18.0, 77.0] 31.0 [19.0, 67.0] 33.0 [18.0, 77.0]
Ethnicity
Hispanic 206 (16.2%) 31 (4.7%) 99 (17.4%) 336 (13.5%)
Not Hispanic 1063 (83.8%) 622 (95.3%) 471 (82.6%) 2156 (86.5%)
Refused/Missing 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Race
Refused/Missing 6 (0.5%) 1 (0.2%) 6 (1.1%) 13 (0.5%)
Black 128 (10.1%) 21 (3.2%) 73 (12.8%) 222 (8.9%)
Other 229 (18.0%) 35 (5.4%) 70 (12.3%) 334 (13.4%)
White 906 (71.4%) 596 (91.3%) 421 (73.9%) 1923 (77.2%)
Education
HS/GED 59 (4.6%) 253 (38.7%) 228 (40.0%) 540 (21.7%)
Less than HS 45 (3.5%) 102 (15.6%) 123 (21.6%) 270 (10.8%)
More than HS 59 (4.6%) 298 (45.6%) 219 (38.4%) 576 (23.1%)
Missing 1106 (87.2%) 0 (0%) 0 (0%) 1106 (44.4%)
Relationship Status
Married or Partnered 26 (2.0%) 186 (28.5%) 55 (9.6%) 267 (10.7%)
Never married 88 (6.9%) 326 (49.9%) 392 (68.8%) 806 (32.3%)
Separated/Divorced/Widowed 48 (3.8%) 139 (21.3%) 123 (21.6%) 310 (12.4%)
Missing 1107 (87.2%) 2 (0.3%) 0 (0%) 1109 (44.5%)
Employment
Full Time 69 (5.4%) 411 (62.9%) 268 (47.0%) 748 (30.0%)
Other 7 (0.6%) 16 (2.5%) 24 (4.2%) 47 (1.9%)
Part Time 34 (2.7%) 116 (17.8%) 116 (20.4%) 266 (10.7%)
Student 1 (0.1%) 28 (4.3%) 10 (1.8%) 39 (1.6%)
Unemployed 52 (4.1%) 82 (12.6%) 151 (26.5%) 285 (11.4%)
Missing 1106 (87.2%) 0 (0%) 1 (0.2%) 1107 (44.4%)
Usual Living Arragements
Stable 153 (12.1%) 651 (99.7%) 534 (93.7%) 1338 (53.7%)
Not Stable 9 (0.7%) 2 (0.3%) 36 (6.3%) 47 (1.9%)
Refused/Missing 1107 (87.2%) 0 (0%) 0 (0%) 1107 (44.4%)

Table 2

Harmonized Urine Drug Screen (UDS) data from the three National Drug Treatment Clinical Trials Network (CTN) opioid use disorder treatment trials

27
(N=26721)
30
(N=10364)
51
(N=10258)
Overall
(N=47343)
Substance
Amphetamine 1150 (4.3%) 254 (2.5%) 310 (3.0%) 1714 (3.6%)
Benzodiazepine 3089 (11.6%) 2049 (19.8%) 1116 (10.9%) 6254 (13.2%)
Cocaine 6595 (24.7%) 704 (6.8%) 800 (7.8%) 8099 (17.1%)
Methamphetamine 1462 (5.5%) 177 (1.7%) 308 (3.0%) 1947 (4.1%)
Opioid 8317 (31.1%) 1850 (17.9%) 1111 (10.8%) 11278 (23.8%)
Oxycodone 947 (3.5%) 2508 (24.2%) 151 (1.5%) 3606 (7.6%)
Propoxyphene 173 (0.6%) 164 (1.6%) 0 (0%) 337 (0.7%)
THC 4988 (18.7%) 2284 (22.0%) 1795 (17.5%) 9067 (19.2%)
Buprenorphine 0 (0%) 374 (3.6%) 4420 (43.1%) 4794 (10.1%)
Barbiturate 0 (0%) 0 (0%) 227 (2.2%) 227 (0.5%)
MDMA 0 (0%) 0 (0%) 20 (0.2%) 20 (0.0%)
27
(N=20961)
30
(N=6287)
51
(N=8638)
Overall
(N=35886)
Temperature In Range
No 25 (0.1%) 16 (0.3%) 40 (0.5%) 81 (0.2%)
Yes 20732 (98.9%) 6242 (99.3%) 8598 (99.5%) 35572 (99.1%)
Missing 204 (1.0%) 29 (0.5%) 0 (0%) 233 (0.6%)

Table 3

Medical and Psychiatric Co-Morbidities in the three National Drug Treatment Clinical Trials Network (CTN) opioid use disorder treatment trials

27
(N=1269)
30
(N=653)
51
(N=570)
Overall
(N=2492)
History of Schiziphrenia
Yes 32 (2.5%) 8 (1.2%) 7 (1.2%) 47 (1.9%)
No 1235 (97.3%) 645 (98.8%) 563 (98.8%) 2443 (98.0%)
Missing/Not Answered 2 (0.2%) 0 (0%) 0 (0%) 2 (0.1%)
History of Major Depression
Yes 352 (27.7%) 215 (32.9%) 179 (31.4%) 746 (29.9%)
No 917 (72.3%) 438 (67.1%) 391 (68.6%) 1746 (70.1%)
Missing/Not Answered 0 (0%) 0 (0%) 0 (0%) 0 (0%)
History of Bipolar Disorder
Yes 147 (11.6%) 37 (5.7%) 79 (13.9%) 263 (10.6%)
No 1121 (88.3%) 615 (94.2%) 491 (86.1%) 2227 (89.4%)
Missing/Not Answered 1 (0.1%) 1 (0.2%) 0 (0%) 2 (0.1%)
History of Anxiety/Panic Disorder
Yes 382 (30.1%) 204 (31.2%) 257 (45.1%) 843 (33.8%)
No 886 (69.8%) 448 (68.6%) 313 (54.9%) 1647 (66.1%)
Missing/Not Answered 1 (0.1%) 1 (0.2%) 0 (0%) 2 (0.1%)
History of Brain Damage
Yes 115 (9.1%) 119 (18.2%) 69 (12.1%) 303 (12.2%)
No 1151 (90.7%) 534 (81.8%) 501 (87.9%) 2186 (87.7%)
Missing/Not Answered 3 (0.2%) 0 (0%) 0 (0%) 3 (0.1%)
History of Epilepsy
Yes 40 (3.2%) 22 (3.4%) 49 (8.6%) 111 (4.5%)
No 1229 (96.8%) 631 (96.6%) 521 (91.4%) 2381 (95.5%)
Missing/Not Answered 0 (0%) 0 (0%) 0 (0%) 0 (0%)
DSM Opiate Diagnosis
Yes 1268 (99.9%) 653 (100%) 570 (100%) 2491 (100.0%)
No 1 (0.1%) 0 (0%) 0 (0%) 1 (0.0%)
Missing/Not Answered 0 (0%) 0 (0%) 0 (0%) 0 (0%)
DSM Alcohol Diagnosis
Yes 251 (19.8%) 0 (0%) 159 (27.9%) 410 (16.5%)
No 843 (66.4%) 0 (0%) 411 (72.1%) 1254 (50.3%)
Missing/Not Answered 175 (13.8%) 653 (100%) 0 (0%) 828 (33.2%)
DSM Amphetamine Diagnosis
Yes 120 (9.5%) 0 (0%) 106 (18.6%) 226 (9.1%)
No 974 (76.8%) 0 (0%) 464 (81.4%) 1438 (57.7%)
Missing/Not Answered 175 (13.8%) 653 (100%) 0 (0%) 828 (33.2%)
DSM Cannabis Diagnosis
Yes 223 (17.6%) 0 (0%) 163 (28.6%) 386 (15.5%)
No 871 (68.6%) 0 (0%) 407 (71.4%) 1278 (51.3%)
Missing/Not Answered 175 (13.8%) 653 (100%) 0 (0%) 828 (33.2%)
DSM Cocaine Diagnosis
Yes 357 (28.1%) 0 (0%) 175 (30.7%) 532 (21.3%)
No 737 (58.1%) 0 (0%) 394 (69.1%) 1131 (45.4%)
Missing/Not Answered 175 (13.8%) 653 (100%) 1 (0.2%) 829 (33.3%)
DSM Sedatives Diagnosis
Yes 153 (12.1%) 0 (0%) 153 (26.8%) 306 (12.3%)
No 941 (74.2%) 0 (0%) 417 (73.2%) 1358 (54.5%)
Missing/Not Answered 175 (13.8%) 653 (100%) 0 (0%) 828 (33.2%)
#> R version 4.3.1 (2023-06-16)
#> Platform: x86_64-apple-darwin20 (64-bit)
#> Running under: macOS Monterey 12.6.9
#> 
#> Matrix products: default
#> BLAS:   /Library/Frameworks/R.framework/Versions/4.3-x86_64/Resources/lib/libRblas.0.dylib 
#> LAPACK: /Library/Frameworks/R.framework/Versions/4.3-x86_64/Resources/lib/libRlapack.dylib;  LAPACK version 3.11.0
#> 
#> locale:
#> [1] C/en_US.UTF-8/en_US.UTF-8/C/en_US.UTF-8/en_US.UTF-8
#> 
#> time zone: America/New_York
#> tzcode source: internal
#> 
#> attached base packages:
#> [1] stats     graphics  grDevices utils     datasets  methods   base     
#> 
#> other attached packages:
#>  [1] public.ctn0094data_1.0.6 psych_2.3.6              infer_1.0.4             
#>  [4] janitor_2.2.0            kableExtra_1.3.4         broom_1.0.5             
#>  [7] DiagrammeR_1.0.10        table1_1.4.3             ggthemes_4.2.4          
#> [10] forcats_1.0.0            tibble_3.2.1             ggplot2_3.4.2           
#> [13] dplyr_1.1.2              conflicted_1.2.0        
#> 
#> loaded via a namespace (and not attached):
#>  [1] gtable_0.3.3       xfun_0.39          bslib_0.5.0        htmlwidgets_1.6.2 
#>  [5] visNetwork_2.1.2   lattice_0.21-8     vctrs_0.6.3        tools_4.3.1       
#>  [9] generics_0.1.3     parallel_4.3.1     fansi_1.0.4        pkgconfig_2.0.3   
#> [13] RColorBrewer_1.1-3 webshot_0.5.5      lifecycle_1.0.3    compiler_4.3.1    
#> [17] stringr_1.5.0      munsell_0.5.0      mnormt_2.1.1       snakecase_0.11.1  
#> [21] htmltools_0.5.5    sass_0.4.6         yaml_2.3.7         Formula_1.2-5     
#> [25] pillar_1.9.0       jquerylib_0.1.4    tidyr_1.3.0        cachem_1.0.8      
#> [29] nlme_3.1-162       tidyselect_1.2.0   rvest_1.0.3        digest_0.6.32     
#> [33] stringi_1.7.12     purrr_1.0.1        fastmap_1.1.1      grid_4.3.1        
#> [37] colorspace_2.1-0   cli_3.6.1          magrittr_2.0.3     utf8_1.2.3        
#> [41] withr_2.5.0        scales_1.2.1       backports_1.4.1    lubridate_1.9.2   
#> [45] timechange_0.2.0   rmarkdown_2.22     httr_1.4.6         memoise_2.0.1     
#> [49] evaluate_0.21      knitr_1.43         viridisLite_0.4.2  rlang_1.1.1       
#> [53] glue_1.6.2         xml2_1.3.4         svglite_2.1.1      rstudioapi_0.14   
#> [57] jsonlite_1.8.5     R6_2.5.1           systemfonts_1.0.4

These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.